Pretreatment Anemia Portends Poor Survival and Nonlocal Disease Progression in Patients with Stage I Non–Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy-Reference-Cited by-同舟云学术

Pretreatment Anemia Portends Poor Survival and Nonlocal Disease Progression in Patients with Stage I Non–Small Cell Lung Cancer Treated with Stereotactic Body Radiation Therapy

Published:2016-08 Issue:8 Volume:11 Page:1319-1325
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Shaverdian Narek,Veruttipong Darlene,Wang Jason,Kupelian Patrick,Steinberg Michael,Lee Percy

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference29 articles.

1. Stereotactic body radiation therapy for inoperable early stage lung cancer;Timmerman;JAMA,2010

2. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer;Crabtree;J Thorac Cardiovasc Surg,2010

3. Reduced lung-cancer mortality with low-dose computed tomographic screening;Abrele;N Engl J Med,2011

4. Long-term results of RTOG 0236: a phase II trial of stereotactic body radiation therapy (SBRT) in the treatment of patients with medically inoperable stage I non-small cell lung cancer;Timmerman;Int J Radiat Oncol Biol Phys,2014

5. Anemia as an independent prognostic factor for survival in patients with cancer;Caro;Cancer,2001

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Developing a clinical-radiomic prediction model for 3-year cancer-specific survival in lung cancer patients treated with stereotactic body radiation therapy;Journal of Cancer Research and Clinical Oncology;2024-01-26

2. Developing a Prediction Model for Radiation Pneumonitis in Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy Combined With Clinical, Dosimetric Factors, and Laboratory Biomarkers;Clinical Lung Cancer;2023-12

3. Patient-Reported and Clinical Outcomes From 5-Fraction SBRT for Oligometastases: A Prospective Single-Institution Study;International Journal of Radiation Oncology*Biology*Physics;2022-12

4. Baseline anemia predicts a poor prognosis in patients with non-small cell lung cancer with epidermal growth factor receptor mutations: a retrospective study;BMC Pulmonary Medicine;2022-10-17

5. Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis;Annals of Translational Medicine;2022-01